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Polyacrylamide gel electrophoresis of the virus-specific proteins synthesized
in vivo upon infection of E. coli with phage AMS21 2 yields three main fractions
designated as proteins I, II, and III, of which protein III is coat protein. Experi-
merits with "amber" mutants indicate that protein JI is a viral RNA synlthetase,
whereas protein I12 ' is a "maturation" protein.4
Translation of the RNA of coliphages by cell-free systems of E. coli gives rise to
coat and other virus-specific proteins.5-8 Two of these proteins have been char-
acterized as RNA synthetase and coat protein.8 The involvement of formyl-
methionine in initiation of coat protein synthesis9' 10 raises the question whether
other virus-specific proteins are similarly initiated. There are some indications
that this is the case.9' 11
The present work was undertaken in order (a) to further characterize the pro-
teins formed upon translation of the MiS2 genome in vitro, and (b) to determine
whether formylmethionine is the chain initiator of proteins other than coat. For
characterization of the proteins synthesized in vitro, the C'4-labeled proteins formed
by a cell-free E. coli system with i\1S2 RNA as messenger were coelectrophoresed
with H3-labeled proteins produced by 1VIS2-infected, actinomycin-treated E. coli
spheroplasts. The in vivo and in vitro proteins I and III were qualitatively identical
but the in vitro system produced protein II to a much lesser extent, if at all. More-
over, the presence of one or more peaks, with a mobility intermediate between that
of proteins II and III, suggested that unfinished or degraded peptides had been
formed. In order to determine whether formylmethionine is involved in the
initiation of both coat protein and protein I, in vitro incubations were conducted
with H'-formyltetrahydrofolic acid and C'4-methionine, and the proteins isolated
by polyacrylamide gel electrophoresis. The two proteins contained HI and C'4
label and both yielded formylmethionine upon digestion with pronase.
Materials and Methods.-Ribosomes, supernatant, and initiation factors: Ribosomes from E. coli
Q13 (a mutant lacking ribonuclease I and polynucleotide phosphorylase) were purified by chro-
matography on O-(diethylaminoethyl) cellulose (DEAE-cellulose) as in previous work.'2 Super-
natant fractions were prepared from E. coli Q13 as described earlier,"3 except that only the upper
two thirds of the supernatant was used. Chain initiation factors (F1 and F2), required for transla-
tion of natural messenger when purified ribosomes are used, were prepared from E. coli Q13 as
previously outlined.'4 They were free of nuclease activity.
Other preparations: RNA from phage MS2 was purified by the method of Strauss and Sin-
sheimer."5 Sucrose density gradient centrifugation of the RNA showed a single peak at 28S. The
preparation was kept frozen for about 3 weeks before use. H'-FTHF'6 was prepared'7 with H3-
formate using formyltetrahydrofolic acid (FTHF) synthetase kindly provided by Dr. J. C. Rabino-
witz, University of California, Berkeley. The H'-FTHF was purified on a column of Whatman
cellulose powder."8 Formylmethionyl-alanine was prepared by formylation of methionyl-alanine.19
The reaction mixture was passed through a column of Dowex 50, H+ form, and the formyl-
methionyl-alanine was eluted with water.
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Amino acid incorporation: (a) C'4-leucine incorporation: Samples contained the following
components in 0.25 ml: Tris-HCl buffer, pH 7.8, 60 mM; ammonium chloride, 50 mM; 2-
mercaptoethanol, 16 mM; magnesium acetate, 14 mM; adenosine 5'-triphosphate (ATP), 1.2
mM; guanosine 5'-triphosphate (GTP), 0.3 mM; phosphocreatine, 18 mM; creatine kinase, 9
MAg; purified E. coli Q13 ribosomes, 14 A60 units; E. coli Q13 supernatant, 50,ul; C'4-leucine,
0.2 mM; each of 19 nonlabeled amino acids, 0.2 mM; E. coli W tRNA, 0.25 mg; with or without
MS2 RNA, 100 Mg; F1, 6.5 MAg of protein; F2, 13 Mg of protein. After 7.5 min at 370, a 100-fold
excess of nonlabeled leucine was added and the incubation continued for 17.5 min. This was
done in order to release unfinished, labeled polypeptide chains from the ribosomes. Aliquots
(5 ,ul) were removed at 8, 15, and 25 min to establish the time at which incorporation of radio-
activity into protein had ceased. Acid-insoluble radioactivity was determined as previously
described. '
(b) H3-FTHF and C'4-methionine incorporation: The incubation mixture was as described for
(a) except for the substitution of nonlabeled for labeled leucine, the substitution of C'4-labeled
for nonlabeled methionine, and the addition of H3-FTHF (2.2 mumoles/0.25 ml). Moreover, the
samples contained one fifth the amount of tRNA (i.e., 0.05 mg/0.25 ml), and the final volume was
2.5 ml. After incubation for 7.5 min at 37°, a 100-fold excess of N5-FTHF and of nonlabeled
methionine was added, followed by incubation for 17.5 min. Aliquots (10,ul) were removed at 9,
15, 20, and 25 min as in (a). They we're diluted with 0.5 ml of water, incubated for 15 min at 370
with 25 jog of RNase, and the acid-insoluble radioactivity was determined as in (a).
Polyacrylamide gel electrophoresis of the proteins synthesized in vitro under the direction of MS2
RNA: The incubation mixture was worked up as described for the fractionation of the virus-
specific proteins synthesized in E. coli spheroplasts infected with MS2 phage.1 Over 90% of the
input radioactivity was recovered from the electrophoretic fractions. In the experiments with
C'4-leucine the proteins were coelectrophoresed with H3-leucine-labeled proteins isolated from
MS2-infected E. coli spheroplasts.'
Characterization of formylmethionine in proteins I and III: Four identical polyacrylamide gel
columns were loaded with H3 formate- and C'4-methionine-labeled proteins, synthesized in vitro
with MS2 RNA as messenger, and simultaneously subjected to electrophoresis. One of the
columns was sectioned and the radioactivity in the slices determined in order to locate the posi-
tion of the protein peaks. Proteins I and III were recovered from the other columns by homoge-
nization of the corresponding sections of the gel and extraction, with freezing and thawing,20
three times in the presence of 0.1 M ammonium bicarbonate, 0.1% sodium dodecylsulfate (SDS),
1% 2-mercaptoethanol. The gel particles were removed by centrifugation, and the supernatant
was dialyzed exhaustively against 0.01 M ammonium bicarbonate for 24 hr. The fractions were
concentrated by flash evaporation and treated with pronase (0.6 mg/ml) for 19 hr at 37°. To
separate the formylated amino acids and peptides from nonformylated ones, the pronase-treated
material was passed through a Dowex 50 column (1 X 16 cm), H+ form; the formylated amino
acids and peptides were eluted with water, concentrated by flash evaporation, and analyzed by
high-voltage paper electrophoresis. The electrophoresis was run in a water-cooled plate at 28
v/cm for 3 or 4 hr. The buffer contained 25 ml of glacial acetic acid and 30 ml of pyridine per
liter. The paper was dried, cut in sections (1-cm long X 3-cm wide), and the radioactivity de-
termined as described for acid-insoluble radioactivity.'
Reagents: H3-formate (2 c/mmole) was obtained from International Chemical and Nuclear
Corp., City of Industry, Calif.; d, I-THF from General Biochemicals, Chagrin Falls, Ohio; pro-
nase from Calbiochem, Los Angeles, Calif.; C'4-leucine (232 mc/mmole) and C'4-methionine (186
inc/mmole) from New England Nuclear Corp., Boston, Mass.; DL-N-formylmethionine from
Sigma Chemical Co., St. Louis, Mo.; I-methionyl-alanine from Mann Research Laboratories,
Inc., New York; atod NO-THF (calcium leucovorin} from the Lederle Laboratories Division, Pearl
River, N. Y. Other reagents were as in previous work.'
Results and Discussion. -In vitro translation of MS2 RNA: A typical coelectro-
phoretic pattern of the MIS2-specific proteins synthesized in vivo and in vitro, with
H3- and C'4-labeled leucine, respectively, is shown in Figure 1. The following
features of the in vitro pattern may be noted. (1) Peaks I and III are qualitatively
normal. The shoulder to the right of peak III appears to be contributed by a
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FIG. 1.-Electrophoretic pattern of proteins synthesized in vitro and
in vivo. Proteins from in vitro (C14-leucine label) and in vivo (H3-leucine
label) incubations were mixed and subjected to' polyacrylamide gel electro-
phoresis. The radioactivity of the fractions was measured simultaneously
in two channels of the Packard liquid scintillation spectrometer. Electro-
phoresis was for 4 hr at 7 v/cm. The anode is to the right in this and
subsequent patterns. Solid line and circles (-@-@-@-), in vitro incuba-
tion with MS2 RNA; dotted line and solid circles (.* ... -*.0 - ), in vitro
incubation without MS2 RNA; dashed line and open circles (-0- -0- -0-),
in vivo incubation (MS2-infected spheroplasts).
nonspecific protein present in the blank, i.e., the sample incubated without added
MS2 RNA. (2) There is but a small peak of radioactivity in the position of pro-
tein II. Its size varies in different incubations and occasionally it is barely dis-
cernible. (3) An additional small peak and some other material, possibly un-
finished peptides and/or degradation products of completed proteins, are seen
between peaks II and III. (4) Although the in vitro system, like that in vivo,
synthesizes more coat protein (peak III) than protein I, relatively much more of the
latter is produced in vitro. Apparently the mechanisms operating in vivo to curb
the synthesis of proteins I and II relatively early in the replication cycle' fail to
function in the in vitro system used here. In vitro synthesis of proteins I and III
has recently been reported by Nathans et al. I
In vitro translation ofMU9 RNA, having anl "amber" mutation in the coat cistron,
gives rise to an electrophoretic pattern virtually identical to that obtained upon
translation of the wild-type RNA, except for the lack of the coat protein peak.
Formylation of proteins I and III: Formylmethionine residues at the amino-
terminal end of biologically synthesized proteins arise from formylmethionylP
tRNA (formylmet-tRNAf) formed by transfer of formate from formyltetrahydro-
folic acid to met-tRNAf.2 In order to determine whether the in vitro translation
of MS2 RNA leads to the incorporation of formylmethionine not only in the coat
protein but also in protein I, incubations were conducted in the presence of H3-
FTHF and C'4-methionine, along with 19 nonlabeled amino acids, and the labeled
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l)roteinls isolated as before by polyacrylamide gel electrophoresis. A typical
electrophoretic patterti is shown in Figure 2.
The following features may be noted. (1) Peaks of H3 and C14 radioactivity
overlap throughout the pattern; hence, formate is incorporated into all the proteins
that incorporate methionine. (2) Protein peaks I and III are again qualitatively
normal but peak II is lacking altogether. (3) Four distinct peaks of radioactivity are
seen in positions intermediate between that correspondiiig to peak II and peak III.
Since the electrophoretic mobility of SDS-protein complexes in polyacrylamide gels
is inversely related to their molecular weight,22 these peaks may be assumed to cor-
respond to peptides smaller thain protein II. These peptides must have arisen
either by translation of p)artially degraded messenger chains, by degradation of some
of the finished l)roteins, or both. lor reasons that will be discussed at another
time we believe that these results are probably due inl the main to messenger deg-
radation. The findings reported here suggest that the degradative processes
affect mainly, if not exclusively, protein II.
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Fi(;. 2.-Electrophoretic pattern of proteins-; synthe-
sized in vitro with H3-TFHF and C'4-methionine. Condi-
tions of electrophoresis as in Fig. 1. H3 radioactivity(-- *-*-) with MXS2 RNA, and (0*@- -0-- 0 -) with-
o(lt MS2 RNA. C14 radioactivity (-0- -0- -o-) with
MS2 1HNA, and ( O.0. .0... ) withont MS2 RNA.
The labeled proteins from sections of the gels corresponding to peaks I and III
were extracted, digested with pronase, and subjected to high-voltage paper electro-
l)horesis, as described under Materials and Alethods, along with markers of formyl-
methionine and formylmethiotnyl-alanine. Whereas enough coat protein was ob-
taimed for this purpose from one column, the pooled fractions from 12 individual
columns were used in the case of protein I which is synthesized in much smaller
amounts. Figure 3A shows, in agreement with previous results,9' 10 the presence
of formylmethionine and formylmethionyl-alanine in the coat protein digest. In
the case of protein I (Fig. 3B) pronase digestion yielded mainly formylmethionine
together with small amounts of formylmethionine-containing peptides.
Since the formyl residues are present only at amino-terminal ends, the ratio H3
radioactivity in coat protein/H3 radioactivity in protein I should be equal to the
ratio iiumber of coat peptide chains/number of protein I peptide chains present at
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FIG. 3.-High-voltage paper elec-
trophoresis of pronase digests of pro-
teins III (A) and I (B) synthesized
in vitro with H3-FTHF (83 X 106
cpm/,gmole) and C14-methionine(144 X 106 cpm/,umole), in the pres-
ence of MS2 RNA. Digests and
markers of formylmethionine and
formylmethionyl-alanine were elec-
trophoresed on Whatman 3 MM
paper for 3 (A) or 4(B) hr at 28
v/cm. Origin at 1 cm. The markers
were spotted by the procedure of
Knight andYoung.23 Their position
on the electropherograms is indi-
cated. H' and C14 radioactivity
were measured simultaneously in
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the end of incubation, provided there is no alteration by deformylation. In the
experiment of Figure 2 this ratio was 15. Thus, many more molecules of coat
protein are made than of protein I. As noted in the preceding section, this excess
would be considerably greater in vivo.
The experimental results presented here support the view that formylmethionine
is involved in initiation of each of the polypeptide chains programed by the poly-
cistronic messenger RNA's of E. coli phages.
We are indebted to Dr. Jerold A. Last for the paper electrophoresis runs and to Mr. Horace
Lozina and Miss Jana Krausova for skillful technical assistance.
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